## Abstract Treatment of gastric cancer has evolved with the advent of randomized trials demonstrating chemotherapeutic agents with efficacy in advanced disease. Level I evidence supports delivering chemotherapy in the neoadjuvant setting; the data shows improvement in progressionβfree and overall
β¦ LIBER β¦
Neoadjuvant Radiochemotherapy in Locally Advanced Gastric Carcinoma
β Scribed by Gunther Klautke; Thomas Foitzik; Kaja Ludwig; Peter Ketterer; Ernst Klar; Rainer Fietkau
- Publisher
- Springer
- Year
- 2004
- Tongue
- German
- Weight
- 237 KB
- Volume
- 180
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Neoadjuvant therapy of locally advanced
β
James J. Mezhir; Laura H. Tang; Daniel G. Coit
π
Article
π
2010
π
John Wiley and Sons
π
English
β 305 KB
Intensified neoadjuvant radiochemotherap
β
Gunther Klautke; Rainer Fietkau
π
Article
π
2006
π
Springer
π
English
β 161 KB
Preoperative neoadjuvant chemoradiation
β
Josef DVORAK; Bohuslav MELICHAR; Jiri PETERA; Karel KABELAC; Milan VOSMIK; Pavel
π
Article
π
2009
π
Wielkopolskie Centrum Onkologii
π
Polish
β 176 KB
Long-Term Results After Neoadjuvant Radi
β
Claudio Coco; Vincenzo Valentini; Alberto Manno; Claudio Mattana; Alessandro Ver
π
Article
π
2006
π
Springer
π
English
β 254 KB
Adjuvant and Neoadjuvant Radiochemothera
β
Thomas B. Brunner; Gerhard G. Grabenbauer; Ulrich Baum; Werner Hohenberger; Rolf
π
Article
π
2000
π
Springer
π
German
β 547 KB
Neoadjuvant chemotherapy in locally adva
β
Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju
π
Article
π
1996
π
John Wiley and Sons
π
English
β 403 KB
π 2 views
Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were